Core Factor (CF) is a conserved RNA polymerase (Pol) I general transcription factor comprising Rrn6, Rrn11 and the TFIIB-related subunit Rrn7. CF binds TATA-binding protein (TBP), Pol I and the regulatory factors Rrn3 and upstream activation factor. We used chemical cross-linking-MS to determine the molecular architecture of CF and its interactions with TBP. The CF subunits assemble through an interconnected network of interactions between five structural domains that are conserved in orthologous subunits of the human Pol I factor SL1. We validated the cross-linking-derived model through a series of genetic and biochemical assays. Our combined results show the architecture of CF and the functions of the CF subunits in assembly of the complex. We extend these findings to model how CF assembles into the Pol I preinitiation complex, providing new insight into the roles of CF, TBP and Rrn3.
a r t i c l e s Each eukaryotic RNA polymerase (Pol I-Pol III) requires its own unique set of general transcription factors (GTFs) to be recruited to promoter DNA, to respond to regulatory signals and to initiate transcription accurately. For Pol I, four GTFs orchestrate the assembly of the Pol I preinitiation complex (PIC): the upstream activating sequence (UAS)-binding upstream activation factor (UAF), the promoter-binding complex Core Factor (CF), TBP and the regulatory GTF Rrn3 (refs. 1,2). Yeast CF comprises three subunits: Rrn6, Rrn11 and the transcription factor IIB (TFIIB)-related subunit Rrn7 (refs. [1] [2] [3] [4] [5] . The human CF ortholog, selectivity factor 1 (SL1), contains five subunits: TAF1A (TAFI48), TAF1B (TAFI63) and TAF1C (TAFI110)-which are orthologs of yeast Rrn11, Rrn7 and Rrn6 (refs. 1,2,6), respectively-metazoan-specific TAF1D (TAFI41) 7 and the TAFII12 subunit shared by SAGA and TFIID 8 .
Pol I PIC formation requires a network of protein-DNA and protein-protein interactions between Pol I, the Pol I GTFs and the rDNA promoter. Yeast rDNA promoters consist of two cis-regulatory elements: the UAS and the core element (CE), which are targeted by UAF and CF during the initial steps of PIC assembly 1, 2 . Human rDNA promoters are also bipartite, consisting of an upstream control element (UCE) and a CE that are targeted by upstream binding factor and SL1, respectively 1, 2, 6 .
Pol I exists both as a dimer that is incapable of initiation and in an initiation-competent form bound by Rrn3, which acts as a bridge between Pol I and the GTFs [9] [10] [11] . Rrn3 folds into an elongated HEATrepeat superhelix that binds to the Pol I A43 subunit and wraps itself along the side of Pol I, passing near the Rpa190 dock domain and the Rpb3 paralog AC40 (ref. 12) . Rrn3 also binds DNA, thereby contributing protein-DNA interactions necessary for Pol I PIC formation 13 . During a typical yeast rDNA transcription cycle, UAF, TBP and CF interact with each other and with promoter DNA to recruit the Pol I-Rrn3 complex 1, 2, 14 .
Pol I has an evolutionarily conserved structural and functional composition shared by its Pol II and Pol III counterparts 15, 16 . All three eukaryotic polymerases contain a core set of five common subunits: Rpb5, Rpb6, Rpb8, Rpb10 and Rpb12. Pols I and III share two additional subunits, AC40 and AC19, which are paralogs of Pol II subunits Rpb3 and Rpb11 (refs. 17,18) . The remaining Pol I-specific subunits are paralogs of Pol II and Pol III subunits or of Pol II GTFs [17] [18] [19] . Pol I exhibits several unique structural features that include a DNAmimicking or extender loop that lies within the cleft, a connector loop that physically links Pol I dimers and a flexible bridge helix 15, 16, 20 , each likely to have a role in regulating Pol I transcription.
There is limited information concerning the architecture of the Pol I PIC and the molecular functions of the Pol I GTFs. The structure of CF, the mechanism of its interaction with Pol I and TBP and its function during transcription initiation are all unknown. Similarly, little is known about the architecture of the human CF ortholog, SL1, a promising target for cancer treatment with molecules that inhibit its DNA-binding function [21] [22] [23] [24] [25] . Here, we have used an integrated approach to determine the molecular architecture of CF and to map the structural and architectural domains essential for its function. Our findings have enabled us to derive a model for the role of CF and its orthologous factor SL1 in Pol I PIC formation and transcription initiation.
RESULTS

Predicted structural domains within Core Factor subunits
Rrn7 is predicted to have domain architecture similar to TFIIB and Brf1 (refs. 1,26,27) . The N-terminal half contains two structured regions-a zinc-ribbon (ZR) domain and tandem cyclin-fold repeats-and an unstructured region analogous to the TFIIB B-reader (BR) and B-linker (BL) regions connects these domains ( Fig. 1 and Supplementary Fig. 1a ). The C-terminal domain (CTD) contains a large Pol I-specific region similar in size and secondary structure to the Brf1 CTD but unrelated in sequence 1, 26 .
Rrn6 and Rrn11 each contain multiple protein repeat motifs that often function as protein-protein interaction interfaces. Rrn11 contains a predicted stretch of seven tetratricopeptide repeats (TPRs) composed of short antiparallel α-helices that typically stack into a superhelical structure 28,29 ( Fig. 1 and Supplementary Fig. 1b ). Its N-and C-terminal portions show no similarity to known protein structures, and the N-terminal domain (NTD) displays a high degree of predicted disorder (Supplementary Fig. 1b ). The N-terminal half of Rrn6 contains a region homologous to WD40 β-propeller proteins 30, 31 , whereas the C-terminal half contains a region that matches helical-bundle (HB) proteins ( Fig. 1c and Supplementary Fig. 1c ). As shown below, these domains all provide structural features important for CF assembly.
Chemical cross-linking and mass spectrometry of CF
We coexpressed the three yeast CF subunits from a single vector in bacteria and purified recombinant CF for use in cross-linking analysis ( Fig. 2) . We tagged Rrn7 and Rrn6 with hexahistidine (His 6 ) for initial affinity purification and then used conventional chromatography to yield a pure stoichiometric complex ( Fig. 2b) capable of restoring Pol I transcription activity of a ∆rrn7 yeast extract deficient in CF function ( Fig. 2c) . Adding back recombinant glutathione S-transferase-tagged Rrn7 alone did not restore transcription activity (Supplementary Fig. 2 ).
We used a combination of chemical cross-linking and MS (CXMS) to map protein-protein interactions within CF. We cross-linked the complex with the homobifunctional reagent BS3, digested with trypsin and analyzed the resulting peptides by MS, using the crosslink database-searching algorithms pLink 32 and Nexus to identify cross-linked peptides and to assemble a linkage map of all the crosslinked peptides within and between the CF protein subunits. The BS3 cross-linker reacts with accessible primary amine groups found in lysine side chains and at the N terminus that are within a theoretical maximum Cα-Cα distance of 30 Å (refs. 30,31,33-36) . Each CF subunit contains 35 or more lysine residues that are well distributed throughout the polypeptides, with the exception of the Rrn11 CTD and Rrn7 ZR and BR domains, which are devoid of lysine residues (Supplementary Fig. 1 ).
All three subunits cross-link with 1:1:1 stoichiometry when CF is incubated with increasing concentrations of BS3 cross-linker, to result in a complex that migrates near the predicted mass sum of the entire complex (~200 kDa) ( Fig. 2d) . MS analysis detected a total of 71 intramolecular and 39 intermolecular cross-links within and between the CF subunits, respectively ( Fig. 3 and Supplementary  Tables 1 and 2) . Among them, 43 were identified by both pLink and Nexus, 33 were identified by pLink only, and 34 were identified by Nexus only. We detected extensive cross-linking between each of the CF subunits, results suggesting an interconnected interaction network in which each CF subunit contacts the other two subunits. This conclusion agrees with bacterial coexpression studies of CFsubunit combinations, in which all pairwise combinations formed stable heterodimers that could be isolated by His 6 -affinity chromatography ( Fig. 2e) . Together, these studies indicate that CF assembles through an extensive network of protein-protein interactions.
Intramolecular cross-linking within CF subunits
We used the intramolecular cross-linking results within the predicted CF domains to validate the cross-linking approach and the molecular modeling of these domains. The predicted Rrn11 TPR domain contains 17 intramolecular cross-links, 14 of which lie within the structure model. All of the Cα-Cα distances between cross-linked lysine pairs are within or close to the theoretical maximum crosslinking distance for BS3 ( Fig. 4a,e ). The predicted Rrn6 WD40 domain contains 13 intramolecular cross-links of which 12 could be measured in the model, and each is within the theoretical BS3 crosslinking distance ( Fig. 4b,e ). We also detected two intramolecular cross-links within the first repeat of the Rrn7 cyclin-repeat domain that are both within allowable BS3 distance constraints ( Fig. 4c,e ). Owing to the limited sequence similarity of HB domains to known structures, it was difficult to obtain a reasonable sequence onlybased homology model. We therefore used Robetta 37 to generate models for the Rrn6 HB domain and the ten intramolecular cross-links as restraints to select the model with the lowest cumulative measured Cα-Cα distance in which all cross-links were within the theoretical BS3 cross-linking distance ( Fig. 4d) . Our combined results support the models for the structured CF domains and validate the crosslinking approach.
Extensive intramolecular cross-linking was also present between regions lacking a predicted three-dimensional structure ( Fig. 3 and Supplementary Table 1 ). We identified five cross-links within the Rrn11 NTD, ten between the Rrn11 NTD and TPR domains and three between the Rrn6 WD40 and HB domains, each of which suggests proximity of those domains. Finally, we identified nine cross-links within the Rrn7 CTD and one cross-link between the Rrn7 CTD and the BL domain.
Intermolecular cross-linking between CF subunits and domains
Many of the intermolecular cross-links are between the predicted CF structured domains ( Fig. 3 and Supplementary Table 2 ). The ten interdomain cross-links detected between the Rrn11 TPR and Rrn6 WD40 domains suggest that these two structural domains physically interact. TPR and WD40 protein-protein interactions are relatively common and have been solved in atomic detail 38, 39 , providing a precedent for a similar interaction within the CF complex. We also detected three cross-links between the Rrn11 TPR and Rrn6 HB domain. Given the proximity of the Rrn6 WD40 and HB domains ( Fig. 3 and Supplementary Table 1 ), the Rrn11 TPR domain would be positioned so that it can interact with both of these Rrn6 domains.
The last five Rrn7 CTD lysine residues cross-link to the Rrn11 NTD and TPR domains and to the Rrn6 WD40 and HB domains. ( Fig. 3 and Supplementary Table 2 ). This positions the Rrn7 CTD at the center of all potential domain contacts. We observed a total of five cross-links between the Rrn7 cyclin-repeat domain and the Rrn6 HB domain, results suggesting potential interaction between these domains.
CF domains important for growth and complex integrity
To test the functional relevance of these cross-linking results, we created a series of CF-subunit variants and determined their impact on cell growth and CF-complex integrity. Rrn7 deletions of the entire cyclin-fold domain, smaller deletions of the cyclin repeats and CTD truncations were all lethal, and the mutants were likewise unable to associate with Rrn6 and Rrn11 ( Supplementary Fig. 3 and summary in Fig. 5 ). This suggests that the cyclin folds and CTD are important protein-protein interaction surfaces for Rrn6 and Rrn11.
There is also a strong correlation between growth phenotypes and the ability of Rrn7 to associate with Rrn6 and Rrn11 ( Fig. 5) , with the exception of the lethal NTD-deletion mutants (ZR, BR and BL), which retain the ability to bind Rrn6 and Rrn11. The Rrn7 BL domain is dispensable for CF integrity, so the cross-linking with the Rrn6 WD40 W1 W2  W3 W4 W5 W6 W7 W8 H1 H2  H3 H4 H5 CTD   Lysine   Intercross-link   Intracross-link  T1  T2 T3 T4 T5 T6  T7 CTD   CTD   Rrn11 BR BL CR1 CR2 ZR npg a r t i c l e s and HB domains is probably not functionally relevant. These findings are consistent with results from previous studies showing that the Taf1B and Brf1 N termini are dispensable for SL1 and TFIIIB complex integrity and promoter recruitment but are necessary for transcription activity at a post-polymerase-recruitment step 1, 26, 27, 40, 41 .
The Rrn7 CTD contains seven predicted tandem helical segments 26 . Rrn11 cross-links near helical segment H3, and deletion of this region is lethal and specifically disrupts the association with Rrn11 but not Rrn6 (Supplementary Fig. 3 ). This phenotype is in excellent agreement with the observation that the region near helical segment H3 cross-links to only Rrn11. Similarly, deletion of Rrn7 helical segments H6 and H7 were also lethal, and both are required for association with Rrn6 and Rrn11 ( Fig. 3 and Supplementary  Fig. 3 ). Finally, targeted deletions of helical segments H1, H2, H4 and H5 gave rise to viable yeast, whereas deletion of H2 and H5 resulted in a slow-growth phenotype; all these deletions support CF formation ( Supplementary Fig. 3b ).
Rrn11-deletion growth and CF-integrity phenotypes also correlate well with the CF cross-linking network ( Fig. 5) . Deletion of the N-terminal portion of the Rrn11 NTD, TPRs 1-3 or TPRs 4-7 were all lethal, whereas deletion of the CTD domain supported wild-type levels of growth ( Supplementary Fig. 4a ). Each of the individual TPR deletions was inviable, with the exception of TPR 7 at the end of the tandem TPR stretch. Cross-linking was present in TPRs 1, 2, 6 and 7, in good agreement with the deletion growth phenotypes showing that TPRs 1-6 are essential. CF-complex integrity analysis of the Rrn11deletion variants is also consistent with the CF cross-linking network. Individual deletions of TPRs 1-5 resulted in reduced association with Rrn6 and Rrn7 ( Supplementary Fig. 4b ), thus indicating a defect in CF-complex assembly. Exceptions are the Rrn11 TPR 6 and the Rrn11 NTD deletions, which still form an intact CF complex but are lethal, thus suggesting that they are important for transcriptional functions outside CF-complex assembly such as interaction with other Pol Iinitiation or Pol I-regulatory factors.
Deletions of the Rrn6 NTD, WD40 and HB domains resulted in lethal growth phenotypes and disrupted CF-complex assembly ( Fig. 5 and Supplementary Fig. 5 ), whereas smaller deletions within the WD40 domain revealed that all WD40 repeats except repeat 2 are necessary for CF-complex integrity (Supplementary Fig. 5b ). Rrn6 WD40-domain deletions are specific to Rrn11, because these deletion variants remain associated with Rrn7. Although we detected no crosslinking with the Rrn6 NTD, it is essential for growth, and the two most extreme N-terminal deletions were defective in Rrn11 association ( Supplementary Fig. 5c,d) . This phenotype resembles that of the Rrn6 WD40-domain deletions and may indicate that the Rrn6-Rrn11 interaction interface extends beyond the WD40 domain into the NTD domain. Overall, our findings agree with the extensive Rrn11 TPR and Rrn6 WD40 cross-linking network and indicate that these two domains function as a major protein interface for CF assembly.
Smaller Rrn6 HB deletions resulted in a range of growth phenotypes. Deletion of helical patch H2 allowed growth at wild-type levels and resulted in formation of an intact CF complex, whereas deletion of patches H3 and H4 resulted in slower-growth phenotypes and caused reduced levels of both Rrn7 and Rrn11 ( Supplementary  Fig. 5a,b) . Deletion of helical patches H1 and H5 was lethal, and mutants exhibited severe reductions in Rrn7 and Rrn11 association. These findings suggest that the Rrn6 HB domain is essential for CF assembly, and they are consistent with the Rrn6 HB cross-linking network of Rrn7 and Rrn11. Finally, the Rrn6 CTD is required for neither growth nor CF-complex integrity, consistently with the absence of cross-linking ( Supplementary Fig. 5a,b ). There is an apparent strict correlation between CF-complex integrity and cell growth, and nearly all of the observed cross-links overlap with essential CF-subunit domains required for complex assembly (Fig. 5) .
Recruitment of CF variants to the rDNA promoter
Five regions of CF are dispensable for complex integrity but essential for cell growth, thus indicating a potential importance for transcriptional activity outside of CF assembly. Because CF plays a key part in Pol I PIC formation, we used chromatin immunoprecipitation Rrn7 ZR BR BL  CR1  CR2  1 2 3  4  5  6 7   CTD  T7  T6  T5  T4  T3  T2  T1  NTD   NTD  W1 W2 W3  W4 W5 W6 W7 W8  H1 H2 H3 H4 Lysine pairs npg a r t i c l e s (ChIP) to determine whether any of these CF mutants retain the ability to bind the rDNA core promoter. As expected, CF mutants defective in CF-complex integrity are also defective in rDNA recruitment (Supplementary Fig. 6 ). Lethal CF mutants retain the ability to form an intact complex and are also defective in rDNA promoter recruitment, thus reflecting their importance in Pol I PIC formation, in which they probably mediate interactions with other Pol I factors and/or promoter DNA. One exception is the modest 50% reduction in Rrn7 ZR∆ recruitment, which mirrors the mutant's similarly reduced protein levels. This is analogous to the Rrn7 ortholog TAF1B and paralog Brf1 ZR∆ mutants, which are still recruited to their respective promoters but are defective for postrecruitment functions 27, 40, 41 .
A model for the structure of CF We used a combination of cross-linking, bioinformatics and protein modeling to derive a topological model of protein-protein interactions required for CF assembly ( Fig. 6 and Supplementary Fig. 7) .
The model shows the predicted protein-protein contacts between each of the CF domains and the interconnectedness of CF assembly. We used interdomain cross-links to orient the CF-domain models so that all of the cross-links satisfy the BS3 cross-linker distance constraints (Fig. 6b,c) . The Rrn6 WD40 and Rrn11 TPR contacts indicated by the cross-linking data are the most intimate; the TPR cradles the WD40 domain through individual TPRs, which provide close contacts with the WD40 repeats. The Rrn6 HB lies at the junction of all three essential CF domains and simultaneously contacts the Rrn7 N-terminal cyclin repeat and CTD in addition to the Rrn6 WD40 and Rrn11 TPR domains. This arrangement explains why targeted deletions within the HB domain are lethal and disrupt CF-complex integrity as well as the observation that deletion of Rrn7 CR causes loss of Rrn11 interaction. Rrn6 and Rrn11 make extensive contacts, and disrupting the Rrn6 HB-domain-Rrn7 CR-domain interaction would probably result in the loss of both proteins. The model predicts that CF forms a globular structure with flexible termini that emanate from a central core composed of interdomain contacts between the Rrn6 WD40, Rrn6 HB, Rrn11 TPR, Rrn7 CR and Rrn7 CTD domains. Mapping interactions between the Rrn7 CTD and other CF domains suggests a key role for the Rrn7 CTD in maintaining CF stability ( Supplementary Fig. 7a,b) . Strikingly, the cross-links in Rrn7-CTD helical segments H6 and H7 are clustered within the central region at the predicted junction between each of the CF domains and suggest that the C-terminal end of the Rrn7 CTD provides an additional surface to link the CF domains together. In addition, Rrn7 CTD lysines found in helical segments H1 and in the linker between H2 and H3 cross-link with two lysines within the first three Rrn11 TPRs. These interactions are likely to act as a separate interaction interface between the Rrn7 CTD and Rrn11 TPR domain, because these regions are also required for complex integrity. Although there is no sequence similarity between the Pol-specific domains of Rrn7 and Brf1, the function of the Rrn7 CTD appears analogous to that of the Brf1 CTD, which is essential for coordinating interactions with other TFIIIB subunits [42] [43] [44] . The following structures were used to create the model: Pol I (PDB 4C2M) 15 , Rrn3 (PDB 3TJ1) 12 , A49 WH (PDB 3NFI) 19 and TBP (PDB 1YTB) 55 
CF-TBP cross-linking
Little is known about the interactions between TBP and the Pol I GTFs. Previous protein interaction assays have suggested that each CF subunit can independently interact with TBP but that the strongest TBP interactions are with Rrn6 (refs. 45, 46) . To examine the interactions between TBP and CF, we cross-linked CF-TBP complexes and identified regions of these factors that were in proximity. We detected 23 intermolecular cross-links between TBP and CF subunits that were clustered in several essential domains within the CF subunits ( Fig. 7 and Supplementary Table 3 ). We also detected 23 intramolecular cross-links within TBP ( Fig. 7 and Supplementary  Table 3 ). We mapped seven of these intramolecular cross-links to the TBP structure, and all fell within the BS3 distance constraints (Supplementary Fig. 8b,c) . Cross-links between the TBP N terminus and CF subunits are less informative because the TBP N terminus is not required for either rDNA transcription or CF and SL1 interaction 47 . We detected ten cross-links between the TBP core domain and CF domains with predicted structures, including the Rrn6 HB and WD40 domains, Rrn11 TPR and NTD domains, and Rrn7 CR and CTD domains ( Fig. 7a and Supplementary Fig. 8a) . These cross-links suggest that several CF domains are in proximity to TBP. Highlighting the lysine residues in the CF model that cross-link to TBP shows that they all reside on a continuous surface that accommodates TBP and DNA (Supplementary Fig. 8d-f) . Together, our results agree with previous reports that all three CF subunits and corresponding SL1 subunits make specific and unique contacts with TBP.
DISCUSSION
Here we describe the molecular architecture of the essential and conserved Pol I CF complex. We discovered that CF assembles through an interconnected network of protein-protein interactions through essential structural domains found in each of the CF subunits. The CF CXMS studies are in excellent agreement with a systematic series of genetic and biochemical results. Our combined results lead to a topological model of the CF complex that explains the roles of many structural domains within CF and provides insight into assembly of the Pol I PIC. The coupling of cross-linking, biological assays and modeling further highlights the usefulness of integrating multiple approaches to understand the architecture and function of macromolecular protein complexes, which are often difficult to decipher by a single experimental approach. (Fig. 8a) . Rrn7 lysines within the cyclin domain that cross-link to the Rrn6 HB domain are accessible and face the empty canyon, pointing toward Rrn3. The Rrn6 HB can also be positioned within the canyon to satisfy the BS3 cross-linking distance constraints (Fig. 8b) . This model explains how Rrn6 mediates simultaneous interactions with Rrn7, Rrn3 and TBP.
Model for architecture of the Pol I PIC
In our Pol I PIC model, the Rrn6 HB domain lies above the Rrn3 HEAT repeats along the side of Pol I. Previous studies have shown that Rrn6 directly interacts with Rrn3 and that the Rrn6 C terminus is sufficient for this interaction and is essential for growth 11 . The tested Rrn6 C-terminal fragment overlaps extensively with the essential H5 region of the Rrn6 HB, which we demonstrate is also important for cell growth, CF-complex integrity and rDNA promoter recruitment, whereas the remainder of the Rrn6 C-terminal region is nonessential. These results suggest that Rrn6 H5 mediates interaction with Rrn3. This agrees well with our positioning of Rrn6 H5 close to Rrn3 and explains the direct interaction between Rrn3 and Rrn6. The Rrn6 HB domain is also positioned close to TBP in the model, and this can explain the Pol I-specific interaction and cross-linking between Rrn6 and TBP 1, 4, 5, 45 . When taken together, the Pol I PIC modeling suggests that the Rrn6 HB acts a protein-protein interaction hub that mediates interactions within the CF complex and between Rrn3 and TBP.
The Pol I PIC modeling also has implications for an additional role of Rrn3 in that it helps coordinate interactions between CF and Pol I by anchoring Rrn6 and possibly the entire CF complex into the transcription-competent configuration within the PIC. This mechanism helps explain why the absence of Rrn3 in the Pol I PIC results in inactive complexes 14, 54 . Furthermore, placement of the CF model into the Pol I PIC also positions portions of the Rrn11 TPR and Rrn6 WD40 near the PIC periphery (Fig. 8c) , where they may interact with other upstream Pol I regulatory factors such as TBP, UAF and possibly the rDNA promoter. This mechanism can explain the defects in the Rrn6 and Rrn11 deletions that result in lethal growth phenotypes but retain CF-complex integrity. The Pol I PIC model will help direct future studies using biochemical and structural approaches to describe these regulatory interactions in greater detail.
Conservation between yeast CF and human SL1 complexes
SL1 subunits TAF1A, TAF1B and TAF1C have been predicted to contain structural features identical to those of the orthologous CF subunits 1 , thus suggesting that the SL1 and CF complexes have similar architecture. However, we note that there are several intriguing differences between CF and SL1 subunits that will be important to address in future studies. For instance, Rrn7 contains a metazoan-specific insertion within the first cyclin-fold repeat that is rich in phosphorylatable residues 1, 26 . Given that the Rrn7 cyclin-fold domain is essential for CF-complex integrity, the insertion may have a regulatory role that impinges upon SL1 assembly or may provide additional sites for interaction with other Pol I factors. The N and C termini of TAF1A and TAF1C are also poorly conserved with their CF counterparts, so these domains may also have species-specific functions in Pol I transcription. Further, it is unclear how the SL1-specific subunits TAF1D and TAFII12 interact with TAF1A-C.
Pol I transcription is upregulated in cancer cells, although the precise molecular mechanism is not clear, and targeting the DNAbinding activity of SL1 has promising anticancer activity [21] [22] [23] [24] [25] . Our study provides the first detailed and systematic analysis, to our knowledge, of the SL1 ortholog, and it should help guide future studies of the structural and mechanistic roles of CF and SL1 and of how they can be targeted to treat cancer and disease.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. npg ONLINE METhODS CF expression and purification. CF was expressed and purified with a similar strategy as described in ref. 56 with several modifications detailed below. Briefly, recombinant CF protein was expressed in BL21 (DE3) RIL cells (Stratagene) by autoinduction in Zy5052 medium (25 mM Na 2 HPO 4 , 25 mM KH 2 PO 4 , 50 mM NH 4 Cl, 5 mM NaSO 4 , 2 mM MgSO 4 , 0.5% glycerol, 0.05% glucose, 0.2% α-lactose, 0.01% tryptone, and 0.005% yeast extract) for 16 h at 37 °C (ref. 57 ). Cells were harvested by centrifugation, and cell pellets were washed once with extraction buffer (50 mM HEPES, pH 8.0, 500 mM KCl, 20 mM imidazole, 5 mM MgCl 2 , 0.1 mM EDTA, 20% glycerol, and 1 mM TCEP) supplemented with protease inhibitors. Cell pellets were resuspended in 5 ml extraction buffer per 1 g of cells, lysed with 1 mg/ml lysozyme (Sigma) for 30 min on ice and sonicated. Lysates were cleared by centrifugation, and cleared lysate was added to Ni-Sepharose affinity medium (GE Healthcare) and incubated for 4 h at 4 °C. CF-bound beads were washed twice with extraction buffer containing 1 M KCl and twice with extraction buffer with 0. Pol I transcription-competent extracts. Pol I transcription-competent extracts were prepared as previously described with minor modifications 58 . Briefly, 1 l of wild-type or rrn7∆ strains were grown to an OD of 1.0 in YP medium containing galactose as a carbon source. Cells were harvested by centrifugation and washed twice with cold extraction buffer (100 mM HEPES-KOH, pH 7.5, 250 mM KCl, 5 mM EGTA, 1 mM EDTA, and 2.5 mM DTT) supplemented with protease inhibitors. Cell pellets were weighed, resuspended in 1.5 ml extraction buffer per gram of cells, and loaded into a syringe. The cell paste was then extruded onto a weigh boat floating over liquid nitrogen to freeze the cells and then was stored at −80 °C. Frozen cells were broken by manual grinding with a mortar and pestle. The resulting cell powder was thawed, and another 1.5 volumes of extraction buffer per gram of cells was added to the ground cells. Broken cells were cleared by centrifugation for 3 h at 100,000g, and the resulting supernatant was dialyzed for a total of 6 h in dialysis buffer (20 mM HEPES-KOH, pH 7.9, 50 mM KCl, 5 mM EGTA, 0.05 mM EDTA, 2.5 mM DTT, and 20% glycerol) supplemented with protease inhibitors and then stored in aliquots at −80 °C. Extracts contained approximately 20 mg/ml protein.
In vitro transcription and primer extension. Transcription assays were as previously described with minor modifications 59 . Briefly, assays were assembled in 50-µl reactions containing 15 µl extract, 1 µl RNase Out (Invitrogen), 100 µM each NTP, 200 µg plasmid template DNA, 10 mg/ml α-amanitin, 12.5 µL 4× transcription buffer (80 mM HEPES-KOH, pH 7.9, 200 mM KCl, 40 mM MgCl 2 , 20 mM EGTA, 0.2 mM EDTA, 10 mM DTT and 40% glycerol). Transcription reactions were incubated at room temperature for 30 min and stopped by addition of 180 µl stop solution (100 mM NaOAc, 10 mM EDTA, and 0.5% SDS) supplemented with 17 µg/ml tRNA (Sigma). RNA was extracted with phenol/ chloroform (2:1) once, ethanol (EtOH) precipitated, and dried. RNA pellets were suspended in 10 µl primer-annealing mix (5 mM Tris, pH 8.3, 75 mM KCl, 1 mM EDTA, and 65 µM fluorescently (700IR) labeled LacI primer). Primerextension reactions were incubated for 45 min at 55 °C; this was followed by addition of 20 µl cDNA-synthesis mix (25 mM Tris, pH 8.3, 75 mM KCl, 4.5 mM MgCl2, 15 mM DTT, 150 µM dNTPs and 100 units MMLV reverse transcriptase (Invitrogen)). Reactions were incubated for 30 min at 37 °C and were stopped by EtOH precipitation. Pellets were washed with 80% EtOH, dried, resuspended in 3 ìl RNase A (40 µg/ml), and incubated for 3 min at room temperature; this was followed by addition of 3 µl formamide loading dye containing bromophenol blue. Resuspended pellets were heated for 1 min at 90 °C, cooled on ice, and run on a denaturing 7% urea acrylamide gel. Gels were visualized by an Odyssey scanner (700 IR, Li-Cor).
CF sequence analysis and structural modeling. PSIpred v3.0 (http://bioinf. cs.ucl.ac.uk/psipred/) was used to predict CF-subunit secondary structure 60 . DISOpred2 was used to predict CF-subunit disordered regions 61 . Confidence values for the predictions were plotted as area graphs for each residue position. Structure-similarity searches were performed by HHpred (http://toolkit. tuebingen.mpg.de/hhpred/) with HMM PDB under default settings and thresholds 62 . Rrn7 NTD, Rrn6 WD40 and Rrn11 TPR domains were searched by HHpred to identify and align homologous proteins of known structure. PIR alignments of the query and target sequences were generated by HHPred with the 'create model' option in the HHPred results page and manually converted to FASTA format. Templates were selected on the basis of the highest probability score and highest protein identity. These alignments were used to generate structural homology models by Modeller 9v10 with the UCSF chimera interface 63 . Ten models of each domain were generated, and the best-scoring model was chosen. The following sequences and templates were used for structural modeling: Rrn7 residues 1-375 aligned with yeast TFIIB residues 1-345 (PDB 4BBR) 64 , Rrn6 WD40 residues 163-559 aligned with human nuclear pore subunit Nup214 residues 1-411 (PDB 2OIT) 65 , and Rrn11 TPR aligned in two overlapping segments, with 129-320 and 208-401 aligned to anaphase-promoting complex subunit CDC26 TPRsubdomain residues 229-431 (PDB 3HYM) 66 . De novo protein structure of the Rrn6 HB domain residues 571-769 was generated by Robetta with default settings and thresholds 67 . The models are reasonable given their low protein identity scores and received good to fair scores on a number of model-evaluation algorithms including ProQ 68 , QMEAN 69 , SelectPro 70 and Verify3D 71 . Model quality results are listed in Supplementary Table 4 . The rigid-body protein-docking program Patchdock 72 was used to guide fitting of the CF domains together and assembly of CF into the Pol I PIC. Default thresholds were used with the exception that the cross-linked lysine Cα distance constraints were included as an added modeling constraint for the docking. The resulting models were then manually optimized to further refine the models and represent a single unique solution.
BS3 cross-linking and mass-spectrometry sample preparation. 50 µg of CF was cross-linked with BS3 (bis[sulfosuccinimidyl] suberate, Thermo Scientific) at a final concentration of 2 mM and 5 mM BS3 for 2 h at room temperature and then stored overnight at 4 °C in 200-µl reactions. For CF-TBP cross-linking, 50 µg of CF was incubated with an equal molar concentration of TBP for 2 h at 4 °C and then passed through a S200 MicroSpin column (GE Healthcare) to remove unbound TBP protein. The CF-TBP complex was then cross-linked with BS3 at a final concentration of 2 mM. An equal volume of trifluoroethanol was added to the BS3-cross-linked protein complex, and the sample was incubated at 60 °C for 30 min to denature the proteins. The proteins were then reduced by addition of 5 mM TCEP for 30 min at 37 °C. The denatured and reduced sample was alkylated with iodoacetamide at a 10-mM final concentration for 30 min in the dark at room temperature. The sample was diluted 10-fold with 20 mM triethanolamine, and the proteins were digested with 1 µg of trypsin overnight at 37 °C. The peptides were further purified on C18 spin columns (Nest Group), dried and resuspended in 5% acetonitrile/0.1% TFA solution and either analyzed by MS or further fractionated by microcapillary SCX HPLC. For HPLC, peptides were loaded onto the column equilibrated in 5% acetonitrile/0.1% TFA and washed with 20% acetonitrile/0.1% formic acid followed by a gradient of 10% acetonitrile/0.1% formic acid containing 10-100 mm ammonium acetate. Remaining column-bound peptides were eluted with 10% acetonitrile/0.1% formic acid containing 1 m ammonium acetate. Most cross-linked peptides were eluted between 50 and 100 mm ammonium acetate, and the peptide fractions were dried down.
Mass-spectrometry analysis and identification of cross-linked peptides.
BS3-cross-linked peptides were analyzed on a Thermo Scientific Orbitrap Elite with HCD fragmentation and serial MS events that included one FTMS1 event at 30,000 resolution followed by ten FTMS2 events at 15,000 resolution. Other instrument settings included: MS mass range greater than 1,800; m/z value as masses enabled; charge-state rejection: +1, +2, and unassigned charges; monoisotopic precursor selection enabled; dynamic exclusion enabled: repeat count 1, exclusion list size 500, exclusion duration 30 s; HCD normalized collision energy 35%, isolation width 3 Da, minimum signal count 5,000; and FTMS MSn AGC target 50,000. The RAW files were converted to mzXML files and analyzed by npg two different cross-link database-searching algorithms: pLink 73 and in housedesigned Nexus (J.L. and J.R., unpublished data).
A protein database containing the forward and reverse sequences was used for the Nexus analysis with the following parameter settings (i) up to three miscleavages; (ii) static modification on cysteines (+57.0215 Da); (iii) differential oxidation modification on methionines (+15.9949 Da); (iv) differential modification on the peptide N-terminal glutamate residues (−18.0106 Da) or N-terminal glutamine residues (−17.0265 Da); (v) differential mono-BS3 modification on lysine residues (+156.0806 Da). All possible tryptic peptide pairs within 20 p.p.m. of the precursor mass are used for cross-linked peptide searches. For each candidate peptide pair, the theoretical b-and y-ion series for each peptide is compared to the acquired spectrum with a modification mass of either the partner peptide and the BS3 linker at the cross-linking site, or a cross-linker-derived lysine immonium ion plus the BS3 linker (modification mass of 221.1416 Da) at the cross-linking site. The score is calculated as the sum of the weighted dot product of the weighted candidate-ion series and the normalized intensity of each fragment ion within 60 p.p.m. of the theoretical fragment ion (similarly to the normalization procedure used by the Sequest algorithm 74 ). The weighted ion matrix considers both the coexistence and connectivity of fragment ions: each candidate ion is weighted 1 at a given charge state; if the preceding ion of the same charge state is present, the score is increased by 0.5, and if not, the score is decreased by 0.5. The same rules apply to the subsequent ion in the ion series. If the weight of an ion equals zero, then a minimum weight of 0.5 is given. The highest candidate score is kept for each spectrum. The false-positive rate (FDR) is calculated as the number of identifications containing one decoy sequence (U) minus the number of identifications containing two decoy sequences (F) divided by the number of identifications containing no decoy sequences (T): FDR = (U − F)/T. This is similar to the FDR calculation used by pLink 73 .
After performing the pLink and the Nexus analysis against a protein database containing the sequences of Core Factor subunits and applying a 5% FDR cutoff, the search results are combined, and each spectrum is manually evaluated for the quality of the match to each peptide with the COMET/Lorikeet Spectrum Viewer (TPP). The cross-linked peptides were considered confidently identified if at least four consecutive b or y ions for each peptide were observed, and the majority of the observed ions were accounted for.
Yeast growth assays. Yeast strains (MATα ade2-1 ade3øhisG ura3-1 his3-11 trp1-1 leu2-112 can1) contained chromosomal deletions of RRN7, RRN6, or RRN11 genes and the plasmid pNOY103 expressing the 35S ribosomal RNA transcript under control of the GAL7 promoter 73, 75, 76 . These yeast strains were transformed with either wild-type or mutant CF-subunit gene derivatives (Supplementary Table 5 ). Cells were grown in galactose complete medium lacking leucine and then streaked on glucose-containing plates to monitor glucose-sensitive phenotypes. Plates were incubated for 3 d at 30 °C and then assessed for growth relative to wild type (+++).
